Recombinant Rat CAPN1 Protein，His

CAPN1, or calpain-1, is a calcium-dependent cysteine protease that plays a crucial role in various cellular processes, including cell signaling, apoptosis, and cytoskeletal remodeling. Dysregulation of CAPN1 has been implicated in several pathological conditions, including neurodegenerative diseases, cardiovascular disorders, and cancer. The study of CAPN1 and its functions has garnered increasing interest due to its potential as a therapeutic target. Recombinant CAPN1 protein production allows for detailed biochemical studies and structural analyses, facilitating the understanding of its enzymatic mechanisms and interactions with substrates. By utilizing techniques such as molecular cloning and expression systems, researchers can generate large quantities of this enzyme, enabling in vitro assays to explore its role in cellular pathways and disease mechanisms. Furthermore, recombinant CAPN1 can be employed in drug screening assays to identify small molecules that modulate its activity, thereby offering insights into novel treatment strategies for related diseases. Overall, the study of CAPN1 through recombinant protein techniques is pivotal, not only for elucidating its biological functions but also for advancing therapeutic interventions targeting calpain-related pathways.